mid term +17,000%
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.